Vaccine hesitancy with a history of Guillain Barre Syndrome: Weighing the risks and benefits of SARS-CoV-2 vaccination
Since the beginning of the COVID-19 pandemic, great hesitancies regarding the COVID-19 immunization have existed. The most striking adverse events reported include thrombosis with thrombocytopenia syndrome (TTS), myocarditis, and Guillain Barre Syndrome (GBS). Post-vaccination GBS is known since the...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-01-01
|
| Series: | IDCases |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2214250922000956 |
| _version_ | 1818238463717146624 |
|---|---|
| author | Aleksandra Murawska Baptista Akankcha Alok Claudia Libertin |
| author_facet | Aleksandra Murawska Baptista Akankcha Alok Claudia Libertin |
| author_sort | Aleksandra Murawska Baptista |
| collection | DOAJ |
| description | Since the beginning of the COVID-19 pandemic, great hesitancies regarding the COVID-19 immunization have existed. The most striking adverse events reported include thrombosis with thrombocytopenia syndrome (TTS), myocarditis, and Guillain Barre Syndrome (GBS). Post-vaccination GBS is known since the time of Influenza vaccination, but several cases of GBS have also been reported in the current COVID-19 vaccination era. As a result, our patient with a history of GBS post-Influenza vaccination, went unvaccinated for SARS-CoV-2, due to fear of GBS re-activation. Consequently, he contracted COVID-19 pneumonitis complicated with deep venous thrombosis, requiring a prolonged hospitalization. Weighing the risks and benefits of vaccination to COVID-19 is difficult, especially for people with a previous history of GBS related to Influenza vaccination. We reviewed and analyzed the reported cases of GBS temporary related to COVID-19 vaccination to determine the safety of their administration in those with a history of GBS. |
| first_indexed | 2024-12-12T12:42:03Z |
| format | Article |
| id | doaj.art-d250cac9aa7946c8b39784630fa555b9 |
| institution | Directory Open Access Journal |
| issn | 2214-2509 |
| language | English |
| last_indexed | 2024-12-12T12:42:03Z |
| publishDate | 2022-01-01 |
| publisher | Elsevier |
| record_format | Article |
| series | IDCases |
| spelling | doaj.art-d250cac9aa7946c8b39784630fa555b92022-12-22T00:24:12ZengElsevierIDCases2214-25092022-01-0128e01467Vaccine hesitancy with a history of Guillain Barre Syndrome: Weighing the risks and benefits of SARS-CoV-2 vaccinationAleksandra Murawska Baptista0Akankcha Alok1Claudia Libertin2Mayo Clinic Alix School of Medicine, Department of Internal Medicine, 4500 San Pablo Rd S, Jacksonville, FL 32224, USA; Corresponding author.Mayo Clinic, 4500 San Pablo Rd S, Jacksonville, FL 32224, USAMayo Clinic Alix School of Medicine, Division of Infectious Diseases, 4500 San Pablo Rd S, Jacksonville, FL 32224, USASince the beginning of the COVID-19 pandemic, great hesitancies regarding the COVID-19 immunization have existed. The most striking adverse events reported include thrombosis with thrombocytopenia syndrome (TTS), myocarditis, and Guillain Barre Syndrome (GBS). Post-vaccination GBS is known since the time of Influenza vaccination, but several cases of GBS have also been reported in the current COVID-19 vaccination era. As a result, our patient with a history of GBS post-Influenza vaccination, went unvaccinated for SARS-CoV-2, due to fear of GBS re-activation. Consequently, he contracted COVID-19 pneumonitis complicated with deep venous thrombosis, requiring a prolonged hospitalization. Weighing the risks and benefits of vaccination to COVID-19 is difficult, especially for people with a previous history of GBS related to Influenza vaccination. We reviewed and analyzed the reported cases of GBS temporary related to COVID-19 vaccination to determine the safety of their administration in those with a history of GBS.http://www.sciencedirect.com/science/article/pii/S2214250922000956COVID-19 infectionCOVID-19 vaccinesGuillain Barre SyndromeImmunization |
| spellingShingle | Aleksandra Murawska Baptista Akankcha Alok Claudia Libertin Vaccine hesitancy with a history of Guillain Barre Syndrome: Weighing the risks and benefits of SARS-CoV-2 vaccination IDCases COVID-19 infection COVID-19 vaccines Guillain Barre Syndrome Immunization |
| title | Vaccine hesitancy with a history of Guillain Barre Syndrome: Weighing the risks and benefits of SARS-CoV-2 vaccination |
| title_full | Vaccine hesitancy with a history of Guillain Barre Syndrome: Weighing the risks and benefits of SARS-CoV-2 vaccination |
| title_fullStr | Vaccine hesitancy with a history of Guillain Barre Syndrome: Weighing the risks and benefits of SARS-CoV-2 vaccination |
| title_full_unstemmed | Vaccine hesitancy with a history of Guillain Barre Syndrome: Weighing the risks and benefits of SARS-CoV-2 vaccination |
| title_short | Vaccine hesitancy with a history of Guillain Barre Syndrome: Weighing the risks and benefits of SARS-CoV-2 vaccination |
| title_sort | vaccine hesitancy with a history of guillain barre syndrome weighing the risks and benefits of sars cov 2 vaccination |
| topic | COVID-19 infection COVID-19 vaccines Guillain Barre Syndrome Immunization |
| url | http://www.sciencedirect.com/science/article/pii/S2214250922000956 |
| work_keys_str_mv | AT aleksandramurawskabaptista vaccinehesitancywithahistoryofguillainbarresyndromeweighingtherisksandbenefitsofsarscov2vaccination AT akankchaalok vaccinehesitancywithahistoryofguillainbarresyndromeweighingtherisksandbenefitsofsarscov2vaccination AT claudialibertin vaccinehesitancywithahistoryofguillainbarresyndromeweighingtherisksandbenefitsofsarscov2vaccination |